Joanna Cyrta

发表

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.

J. Limacher, O. Lantz, E. Piaggio, 2023, European journal of cancer.